Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Cleo J Chivikas Connolly
Introduction
Cleo J Chivikas Connolly is a notable inventor based in Livonia, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work has implications for treating various cell proliferative disorders, including cancer.
Latest Patents
Cleo J Chivikas Connolly holds 1 patent for his invention related to kinase inhibitors. This invention provides phenyl-substituted pyrimidopyrimidines, dihydropyrimido-pyrimidines, pyridopyrimidines, naphthyridines, and pyridopyrazines that inhibit cyclin-dependent kinase and tyrosine kinase enzymes. The patent also includes methods and intermediate compounds for their synthesis, as well as pharmaceutical compositions and methods for their use in treating, inhibiting, or preventing maladies associated with cell proliferative disorders, including angiogenesis, atherosclerosis, restenosis, and cancer.
Career Highlights
Cleo J Chivikas Connolly has worked at Warner-Lambert Company, where he has been able to apply his innovative ideas in a practical setting. His contributions have been instrumental in advancing the company's research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Cleo has collaborated with notable colleagues, including Christopher James Deur and James Marino Hamby. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Cleo J Chivikas Connolly's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to kinase inhibitors highlight the importance of research in developing treatments for serious health conditions.